Health News

News > Health News

RSS Feed

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

1:30 AM on Sunday, October 19

KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer

9:35 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial

9:35 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

9:30 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial

9:30 AM on Saturday, October 18

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial

9:30 AM on Saturday, October 18

Nurse Rod Salaysay plays guitar for patient Richard Hoang in the recovery unit of UC San Diego Health in San Diego, Calif., on Sept. 30, 2025. (AP Photo/Javier Arciga)

Music could help ease pain from surgery or illness. Scientists are listening

8:04 AM on Saturday, October 18

Hospitals and doctors' offices are inviting singers and musicians to help patients manage their pain, as music's ability to reduce pain is gaining attention

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

6:00 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen

5:00 AM on Saturday, October 18

Third-floor balcony in Cincinnati collapses, sending 10 people to the hospital

11:12 PM on Friday, October 17

Officials say a balcony on the third floor of a building near the University of Cincinnati has collapsed, sending 10 people to the hospital

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

3:17 PM on Friday, October 17

First ... 11 12 13 14 15 ... Last

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • Chicago's Morning Answer
    5:00AM - 9:00AM
     
    Each morning, Dan Proft starts your day with the latest news and why it's important and what it means for you.
     
  • The Mike Gallagher Show
    9:00AM - 11:00AM
     
    Mike Gallagher is one of the most listened-to radio talk show hosts in America.   >>
     
  • The Charlie Kirk Show
    11:00AM - 1:00PM
     
    "The Charlie Kirk Show" can be heard weekdays across Salem Radio Network and watched on The Salem News Channel.
     
  • The Scott Jennings Show
    1:00PM - 2:00PM
     
    Jennings is battle-tested on cable news, a veteran of four presidential   >>
     
  • The Hugh Hewitt Show
    2:00PM - 4:00PM
     
    Hugh Hewitt is one of the nation’s leading bloggers and a genuine media   >>
     

See the Full Program Guide